TNL Mediagene Regains Nasdaq Bid‑Price Compliance, Panel Monitor Imposed

TNMG
January 22, 2026

TNL Mediagene confirmed that its ordinary shares have met Nasdaq’s bid‑price rule, having traded at $1.00 or higher for fifteen consecutive trading days from December 23, 2025 through January 14, 2026. The company received a letter from Nasdaq on January 20, 2026 confirming the compliance, and the Nasdaq Hearings Panel issued a decision on December 19, 2025 that imposed a one‑year discretionary panel monitor under Listing Rule 5815(d)(4)(A). The monitor requires the company to maintain the $1.00 threshold and allows Nasdaq to act without a cure period if non‑compliance recurs.

The compliance milestone follows a 1‑for‑20 reverse share split announced on December 19, 2025, which was part of a remediation plan designed to lift the share price above the minimum requirement. Earlier in 2025, Nasdaq had issued a deficiency notice in May and granted a conditional listing extension in December that required the company to regain compliance by January 7, 2026. The panel’s decision to impose a monitor reflects Nasdaq’s intent to closely scrutinize TNL Mediagene’s ongoing adherence to listing standards.

While the announcement removes the immediate risk of delisting, the panel monitor signals that Nasdaq will enforce compliance more strictly during the next year. TNL Mediagene has faced significant financial challenges, reporting net losses and raising concerns about its ability to continue as a going concern in its most recent earnings. The company’s share price has been volatile, with a 52‑week low of $1.94 and a recent upward trend, indicating investor sensitivity to both the regulatory outcome and the underlying financial health.

Investors reacted positively to the compliance confirmation, but the panel monitor introduces a cautionary element. Analysts noted that while the company has avoided delisting, its financial performance remains a headwind, and the ongoing regulatory scrutiny may limit the upside potential until the company demonstrates sustained profitability and compliance.

Looking ahead, TNL Mediagene must maintain the $1.00 bid‑price threshold and address its financial weaknesses. Management has emphasized the importance of cost discipline and strategic investments in its AI‑driven advertising services, aiming to strengthen revenue streams and improve profitability. The company’s ability to navigate the panel monitor period will be closely watched as a barometer of its long‑term viability in the U.S. capital markets.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.